Skip to main content
. 2020 Jul 2;13(7):e233842. doi: 10.1136/bcr-2019-233842

Figure 2.

Figure 2

Programmed cell death-ligand 1 (PD-L-1) pathway. (A) Upregulation of programmed cell death protein 1 (PD-1) pathway leads to increased inhibition of T cell/ immune response. (B) Inhibition of the PD-1 pathway via anti-PD-L1 leads to upregulation of immune response. MHC, major histocompatibility complex; TCR, T cell receptor.